144 related articles for article (PubMed ID: 2203302)
21. Rapid detection of mutations in the human-derived Pneumocystis carinii dihydropteroate synthase gene associated with sulfa resistance.
Ma L; Kovacs JA
Antimicrob Agents Chemother; 2001 Mar; 45(3):776-80. PubMed ID: 11181359
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
[TBL] [Abstract][Full Text] [Related]
23. Sulfa resistance in mouse-derived Pneumocystis carinii.
Lane B; Hossler P; Bartlett M; Queener S; O'Reilly T; Smith J; Meshnick S
J Eukaryot Microbiol; 1996; 43(5):39S. PubMed ID: 8822842
[No Abstract] [Full Text] [Related]
24. Quantitative structure-activity analysis in dihydropteroate synthase inhibition by sulfones. Comparison with sulfanilamides.
De Benedetti PG; Iarossi D; Menziani C; Caiolfa V; Frassineti C; Cennamo C
J Med Chem; 1987 Mar; 30(3):459-64. PubMed ID: 3546688
[TBL] [Abstract][Full Text] [Related]
25. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia.
Visconti E; Ortona E; Mencarini P; Margutti P; Marinaci S; Zolfo M; Siracusano A; Tamburrini E
Int J Antimicrob Agents; 2001 Dec; 18(6):547-51. PubMed ID: 11738342
[TBL] [Abstract][Full Text] [Related]
26. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
Stein CR; Poole C; Kazanjian P; Meshnick SR
Emerg Infect Dis; 2004 Oct; 10(10):1760-5. PubMed ID: 15504261
[TBL] [Abstract][Full Text] [Related]
27. Quantitative structure-activity relationships in dihydropteroate synthase inhibition by multisubstituted sulfones. Design and synthesis of some new derivatives with improved potency.
De Benedetti PG; Iarossi D; Folli U; Frassineti C; Menziani MC; Cennamo C
J Med Chem; 1989 Oct; 32(10):2396-9. PubMed ID: 2677378
[TBL] [Abstract][Full Text] [Related]
28. Rapid detection of dihydropteroate polymorphism in AIDS-related Pneumocystis carinii pneumonia by restriction fragment length polymorphism.
Helweg-Larsen J; Eugen-Olsen J; Lundgren B
Scand J Infect Dis; 2000; 32(5):481-3. PubMed ID: 11055650
[TBL] [Abstract][Full Text] [Related]
29. Dihydropteroate synthase polymorphisms in Pneumocystis carinii.
Lane BR; Ast JC; Hossler PA; Mindell DP; Bartlett MS; Smith JW; Meshnick SR
J Infect Dis; 1997 Feb; 175(2):482-5. PubMed ID: 9203679
[TBL] [Abstract][Full Text] [Related]
30. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
Allegra CJ; Boarman D; Kovacs JA; Morrison P; Beaver J; Chabner BA; Masur H
J Clin Invest; 1990 Feb; 85(2):371-9. PubMed ID: 2298911
[TBL] [Abstract][Full Text] [Related]
31. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients.
Armstrong W; Meshnick S; Kazanjian P
Microbes Infect; 2000 Jan; 2(1):61-7. PubMed ID: 10717542
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs.
Zhang Y; Meshnick SR
Antimicrob Agents Chemother; 1991 Feb; 35(2):267-71. PubMed ID: 2024960
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of multiple loci suggests that mutations in the Pneumocystis carinii f. sp. hominis dihydropteroate synthase gene arose independently in multiple strains.
Ma L; Kovacs JA
Antimicrob Agents Chemother; 2001 Nov; 45(11):3213-5. PubMed ID: 11600382
[TBL] [Abstract][Full Text] [Related]
34. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum.
Triglia T; Menting JG; Wilson C; Cowman AF
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13944-9. PubMed ID: 9391132
[TBL] [Abstract][Full Text] [Related]
35. [Use of restriction fragment length polymorphism to detect dihydropteroate synthase gene mutations in strains of Pneumocystis jirovecii isolated in Poland].
Gołab E
Med Dosw Mikrobiol; 2007; 59(2):177-82. PubMed ID: 17929415
[TBL] [Abstract][Full Text] [Related]
36. Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain.
Friaza V; Morilla R; Respaldiza N; de la Horra C; Calderón EJ
Postgrad Med; 2010 Nov; 122(6):24-8. PubMed ID: 21084778
[TBL] [Abstract][Full Text] [Related]
37. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation.
Huang L; Morris AM; Beard CB
J Eukaryot Microbiol; 2001; Suppl():180S-181S. PubMed ID: 11906054
[No Abstract] [Full Text] [Related]
38. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.
Kazanjian P; Armstrong W; Hossler PA; Burman W; Richardson J; Lee CH; Crane L; Katz J; Meshnick SR
J Infect Dis; 2000 Aug; 182(2):551-7. PubMed ID: 10915088
[TBL] [Abstract][Full Text] [Related]
39. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
Fernley RT; Iliades P; Macreadie I
Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
[TBL] [Abstract][Full Text] [Related]
40. Genetic divergence of the dihydrofolate reductase and dihydropteroate synthase genes in Pneumocystis carinii from 7 different host species.
Ma L; Imamichi H; Sukura A; Kovacs JA
J Infect Dis; 2001 Nov; 184(10):1358-62. PubMed ID: 11679931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
